Pfenex Inc (NYSE American:PFNX)

6.91
Delayed Data
As of May 21
 -0.13 / -1.85%
Today’s Change
2.07
Today|||52-Week Range
8.42
+159.77%
Year-to-Date
No recent news for Pfenex Inc.

Today’s Trading

Previous close7.04
Today’s open7.05
Day’s range6.82 - 7.10
Volume85,072
Average volume (3 months)123,858
Market cap$143.9M
Data as of 8:00pm ET, 05/21/2018

Growth & Valuation

Earnings growth (last year)-573.91%
Earnings growth (this year)-60.24%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.19%
P/E ratioNM
Price/Sales2.17
Price/Book2.49

Competitors

 Today’s
change
Today’s
% change
CFRXContraFect Corp+0.04+2.21%
SRRASierra Oncology Inc-0.05-1.91%
PLXProtalix Biotherapeu...-0.01-1.16%
ADMAADMA Biologics Inc-0.26-4.78%
Data as of 4:00pm ET, 05/21/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$28.8M
Annual profit (last year)-$25.7M
Net profit margin-89.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary &
Director
Evert Schimmelpennink
Chief Financial Officer
Susan A. Knudson
Corporate headquarters
San Diego, California

Forecasts